Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide in Hepatic Encephalopathy Patients
NCT02334163Phase 2Unknown
- Sponsor
- Ain Shams University
- Start
- Dec 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of nitazoxanide in hepatic encephalopathy (HE) (3 arms), sponsored by Ain Shams University. Primary endpoint: Clinical Hepatic Encephalopathy Staging Scale at 7 days. Status: unknown.
02
Drugs
nitazoxanide
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT02334163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02334163.